Search clinical trials for: follitropin alfa

Total 10558 results

Ferring Pharmaceuticals

Recruiting

A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China (COCO)

Infertility, Female

China
Changchun GeneScience Pharmaceutical Co., Ltd.
Sixth Affiliated Hospital, Sun Yat-sen University

Recruiting

To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (ANGAS)

Infertility

China
Instituto Bernabeu

Recruiting

Continuous Double Ovarian Stimulation.

Fertility Issues

Spain
Peter Kovacs MD

Recruiting

Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders

Infertility | Ovarian Dysfunction

Hungary
Peking University Third Hospital

Not yet recruiting

Traditional Chinese Medicine Herbs in the Freeze-all IVF Cycle

Infertility, Female
Peking University Third Hospital

Recruiting

Acupuncture in the Freeze-all IVF Cycle

Acupuncture | Female Infertility

China
Peking University Third Hospital

Recruiting

Sequential Therapy of TCM Herbs to Improve the Success Rate of IVF-ET in Diminished Ovarian Reserve Patients

Infertility, Female

China
University Hospital, Ghent

Recruiting

Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders (MONACO)

IVF | Ovarian Reserve | Poor Responders

Belgium
Organon and Co

Completed

Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031)

Infertility
Ferring Pharmaceuticals

Active, not recruiting

A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation (ADAPT-1)

Infertility

Austria, France, Italy, Spain, United Kingdom
Organon and Co

Completed

A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)

In Vitro Fertilization
Organon and Co

Completed

To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001) (Ensure)

Infertility
IRCCS San Raffaele

Completed

Reduction of Progesterone Elevation at Trigger in POR After Long Acting COS Compared With Daily COS: a Prospective Randomized Trial (PE-PMA)

Infertility

Italy
Copenhagen University Hospital at Herlev
Copenhagen University Hospital, Hvidovre

Active, not recruiting

Estradiol and Progesterone Levels Following Frozen Embryo Transfer (ESTRO-FET)

Infertility

Denmark
CRG UZ Brussel
Merck KGaA, Darmstadt, Germany

Withdrawn

Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders

Poor Response to Ovulation Induction
Ferring Pharmaceuticals

Completed

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in India Women (IRIS)

Infertility

India
Ferring Pharmaceuticals

Completed

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2 (ESTHER-2)

Infertility

Canada, Belgium, Brazil, Czechia, Denmark, France, Italy, Poland, Russian Federation, Spain, United Kingdom
Ferring Pharmaceuticals

Completed

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women

Controlled Ovarian Simulation

Korea, Republic of, Taiwan, China, Vietnam
Instituto Valenciano de Infertilidade de Lisboa
Merck Sharp & Dohme LLC

Completed

Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity

Infertility, Female | Endometrial Diseases

Portugal
Universitair Ziekenhuis Brussel
Merck Sharp & Dohme LLC

Completed

Optimisation of Follicular Recruitment in IVM Cycles (Elonva_IVM)

Polycystic Ovary Syndrome | Infertility, Female

Belgium
Lund University
Ferring Pharmaceuticals

Completed

Hormone Evaluation in Artificial Reproductive Technology (HEART)

Female Infertility

Poland, Sweden
IVFarma LLC
BridgePharm LLC; GlobalPharma LLC

Completed

Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment

Infertility, Female

Russian Federation
Organon and Co

Completed

Pregnancy & Neonatal Follow-up of Ongoing Pregnancies Established During Clinical Trial 38826 (Study 38827)(P06056)(COMPLETED)

Pregnancy | Neonates
Organon and Co

Completed

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)

Pregnancy | Neonates
Organon and Co

Completed

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710) (Care)

Pregnancy | Neonates
Organon and Co

Completed

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Phase II Clinical Trials of Org 36286 (Study 38817)(P06054)(COMPLETED)

Pregnancy
Organon and Co

Withdrawn

An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)

Infertility
Organon and Co

Completed

Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)

In Vitro Fertilization
Organon and Co

Completed

A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)

Fertilization
Organon and Co

Completed

Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)

In Vitro Fertilization
Organon and Co

Completed

Efficacy and Safety Study of a Single Injection of SCH 900962 Versus Daily recFSH Injections in Women Undergoing Controlled Ovarian Stimulation (Study P06029) (PURSUE)

Infertility
Ferring Pharmaceuticals

Completed

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1 (ESTHER-1)

Infertility

Canada, Belgium, Brazil, Czechia, Denmark, France, Italy, Poland, Russian Federation, Spain, United Kingdom
Merckle GmbH

Completed

Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young Women

Bioequivalence
IVFarma LLC
Institute for Preventive and Social Medicine

Completed

An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data

Fertility Issues | Fertility Disorders | IVF | Gynecologic Disease | Reproductive Issues | Reproductive Disorder

Russian Federation
Merck KGaA, Darmstadt, Germany
Merck Serono GmbH, Germany; Merck B.V., Netherlands; Merck A.E., Greece; Merck... and other collaborators

Completed

PERgoveriS In Stratified Treatment for Assisted Reproductive Technique (PERSIST)

Assisted Reproductive Techniques | Reproductive Technology, Assisted

Italy, Russian Federation, United Kingdom, Germany, Poland, Finland, Slovakia, Netherlands, Denmark, France, Greece
Glycotope GmbH
Glycotope Biotechnology GmbH

Completed

Single Dose FSH-GEX™ in Healthy Volunteers

Female Infertility

Netherlands
Glycotope GmbH

Completed

Efficacy and Safety of FSH-GEX™ in Comparison With 150 IU Gonal-f®

Infertility

Germany, Hungary
IBSA Institut Biochimique SA

Completed

FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST) (FAST)

Infertility

Italy, Belgium, Turkey, Spain, Switzerland, United Kingdom
D.O. Ott Research Institute of Obstetrics, Gynecology...

Completed

Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders (TEMPER)

Infertility, Female

Russian Federation
IVFarma LLC
NADIM LLC

Completed

The Safety and Pharmacokinetics of Primapur and Gonal-f

Pharmacokinetics | Absorption | Area Under Curve

Russian Federation
Hospital Central "Dr. Ignacio Morones Prieto"
Universidad Autonoma de San Luis Potosí

Unknown

Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.

Respiratory Distress Syndrome | Bronchopulmonary Dysplasia | Infant,Premature

Mexico
Merck KGaA, Darmstadt, Germany
Merck Ltd.

Completed

A Korean Post-Marketing Surveillance Study On Pergoveris® (Follitropin Alfa + Lutropin Alfa)

Infertility

Korea, Republic of
Universitair Ziekenhuis Brussel
Erasme University Hospital; AZ Jan Palfijn Gent

Unknown

Effect of Recombinant Follicular Stimulating Hormone (FSH) Dosing Following Cori-follitropin Alfa (TBC)

Infertility
Merck KGaA, Darmstadt, Germany

Completed

Lutropin Alfa in Women at Risk of Poor Response

Ovarian Stimulation

Spain
Fertility Biotech AG

Completed

Comparative Pharmacokinetics of AFOLIA and US Gonal-f® RFF Redi-ject After Single Subcutaneous Application

Healthy Volunteers

United Kingdom
Alphamab Jilin Co., Ltd.

Unknown

Study on the Safety and Pharmacokinetics of LM001 and Gonal-F® in Healthy Women

Infertility, Female
Merck KGaA, Darmstadt, Germany

Completed

Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization (Prestyje)

Infertility | Ovulation Induction | In-Vitro Fertilization

Germany
Merck KGaA, Darmstadt, Germany

Completed

Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF) (CONSORT)

Infertility

France
Merck KGaA, Darmstadt, Germany

Completed

A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve

Infertility | Ovulation Induction

Spain
Fertility Biotech AG

Completed

Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF

Infertility

United States

3

Subscribe